Home
Scholarly Works
Gefitinib does not improve survival when combined...
Journal article

Gefitinib does not improve survival when combined with gemcitabine and cisplatin in people with advanced non-small-cell lung cancer Abstracted from: Giaccone G, Herbst RS, Manegold C et al. Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer: a phase III trial-INTACT 1. J Clin Oncol 2004;22:777–784.

Authors

Evans WKB

Journal

Cancer Treatment Reviews, Vol. 30, No. 7, pp. 651–653

Publisher

Elsevier

Publication Date

November 1, 2004

DOI

10.1016/j.ctrv.2004.08.001

ISSN

0305-7372

Contact the Experts team